Ezra's Notes Checked November 16, 2026
Investor Holdings

By @ezracrangle

← Thomas Gayner, latest 13F

Regeneron Pharmaceuticals

In Thomas Gayner's portfolio · Markel Group

Ticker REGN

Not in the portfolio as of Q3 2026. Every quarter it shows up in a Markel Group 13F, newest first.

QuarterActivitySharesWeightPriceValue
Q3 2022 No change 80,300 0.8% $688.88 $55.3M
Q2 2022 No change 80,300 0.7% $591.12 $47.5M
Q1 2022 Add 1% 80,300 0.7% $698.42 $56.1M
Q4 2021 Add 7% 79,300 0.6% $631.53 $50.1M
Q3 2021 Add 11% 74,300 0.6% $605.18 $45.0M

Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.